Portable and versatile Point-of-care diagnostics

Description

Details Status Upcoming Reference HORIZON-HLTH-2027-02-IND-02-two-stage Publication date 8 October 2026 in Funding and Tenders Portal Opening date 29 October 2026 Deadline model Two-stage Deadline date 17 February 2027, 17:00 (CET) Funding programme Horizon Europe – the Framework Programme for Research and Innovation (2021/2027) Programme Sector Health Programme Horizon Europe Horizon Europe Cluster 1: Health Tags HealthUnion Medical research Description Point-of-Care (PoC) medical testing has made great technical progress (e.g. improved extraction, microfluidics, miniaturisation, and data processing techniques) with PoC test accuracies nearly matching those of lab-based tests. PoC tests may thus be an alternative to laboratory testing methods, enabling faster diagnostic results and therapeutic decision making. However, PoC testing is not always achieving a completely accurate diagnosis and one of the major issues with PoC diagnostics is the occurrence of false results during testing, another one is the often-cumbersome sample preparation. Hence there is a need for PoC diagnostics that are more sensitive, selective and easy-to-use allowing for improved clinical practice. The selection of the PoC device to be developed or optimised should be based on an objectively conducted clinical needs assessment, which includes -next to clinicians’ perspectives- the complete care pathway and system-level needs. Moreover, a value-based concept should be applied in the choice and development of the PoC device, taking into account its Health Technology Assessment (HTA) by the relevant HTA bodies, in order to facilitate their decisions for adoption. Proposals should be driven by a clear clinical need, integrate a value-based concept and include all the following activities: The optimisation of (the) targeted PoC diagnostic device(s) that take(s) the above-mentioned criteria, challenges and aspects into consideration. The elaboration of a comparative study clearly demonstrating the added value and improved performance of the optimised PoC diagnostic device(s) as compared to the current state of the art for the targeted diagnostic application. The conduct of clinical studies of (the) optimised PoC diagnostic medical device(s) as a preferred information source for their clinical validation; subsequent conformity assessment in agreement with requisite EU’s In-Vitro Medical Device (IVDR) or Medical Device (MDR) regulatory requirements. Read more and apply on the Funding and Tenders Portal .

Sectors

Source

Source: hadea.ec.europa.eu